Clinical Trial Update: Evaluation of Biodentine Versus Glass Ionomer Cement in Treatment of Very Deep Carious Lesions [Phase 3]

View source ↗

Summary

Phase 3 clinical trial comparing Biodentine to glass ionomer cement for very deep carious lesions has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Deep Caries

Drugs mentioned

• Biodentine (tricalcium silicate cement)
• Glass Ionomer Cement (glass ionomer cement)

Snippet

Sponsor: Cairo University | Conditions: Deep Caries | Phase 3 | Status: COMPLETED